Showing 2 of 2 recruiting trials for “Coccidioidomycosis”
Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
RecruitingNCT02190266 ↗
Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
👨⚕️ Steven M Holland, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Sep 2014View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →